A78.full
Loading viewer...
report
Format: PDF report
This report evaluates the efficacy of NKX019, a CD19-targeting CAR NK cell therapy, showcasing its potential in treating B-ALL with enhanced cytolytic activity.
Loading viewer...
report
Format: PDF report
This report evaluates the efficacy of NKX019, a CD19-targeting CAR NK cell therapy, showcasing its potential in treating B-ALL with enhanced cytolytic activity.
report
A. O. Smith Corporation
report
Imerys
report
Smile Brands
report
Kenvue
